Successful Treatment of Guillain-Barré Syndrome with Combined Administration of Interferon-β-1a and Intravenous Immunoglobulin

Publisher： Karger

E-ISSN： 1421-9913|46|3|167-168

ISSN： 0014-3022

Source： European Neurology, Vol.46, Iss.3, 2001-10, pp. : 167-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Side Effects of Combined Therapy of Methylprednisolone and Intravenous Immunoglobulin in Guillain-Barré Syndrome

By  

European Neurology, Vol. 53, Iss. 4, 2005-07 ,pp. : 194-196

Karger

Access to resources Recommend Favorite

A Preliminary, Randomized, Multicenter Study Comparing Intravenous Immunoglobulin, Plasma Exchange, and Immune Adsorption in Guillain-Barré Syndrome

By  

European Neurology, Vol. 46, Iss. 2, 2001-08 ,pp. : 107-109

Karger

Access to resources Recommend Favorite

‘Hyperacute’ Guillain-Barré Syndrome

By  

European Neurology, Vol. 59, Iss. 1-2, 2007-10 ,pp. : 88-90

Karger

Access to resources Recommend Favorite

Guillain-Barré Syndrome after H1N1 Influenza: A Concern

By  

Neuroepidemiology, Vol. 40, Iss. 4, 2013-03 ,pp. : 295-295

Karger

Access to resources Recommend Favorite

The Epidemiology of Guillain-Barré Syndrome Worldwide

By  

Neuroepidemiology, Vol. 32, Iss. 2, 2008-12 ,pp. : 150-163

Karger

Access to resources Recommend Favorite